Ascendis Pharma A/S 4

Flemming Steen Jensen, an EVP at Ascendis Pharma A/S, sold 19,460 ordinary shares for roughly $4.6 million and reported no direct shares remaining.

On May 11, 2026, Flemming Steen Jensen, EVP & Product Supply and Quality of Ascendis Pharma A/S, reported an open-market sale of 19,460 ordinary shares at an average price of approximately $238.49 per share, for total proceeds of about $4.6 million. Following this disposition, the insider reported no directly held ordinary shares remaining, indicating a full sale of his reported directly owned position in the company.

Filing Facts

CIK

1612042

Ticker

ASND

Form

4

Source Type

sec

Accession

0001610717-26-000159

Alert Tier

7